ScholarIQanswers from OpenAlex & ORCID
Luis López Lázaro
ResearcherPublications, citations & collaboration network
Luis López Lázaro is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Luis López Lázaro have?
ScholarIQindexed works
Luis López Lázaro has 100 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Luis López Lázaro have?
ScholarIQcitation count
Luis López Lázaro has 2,035 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Luis López Lázaro?
ScholarIQh-index
Luis López Lázaro has an h-index of 27 in OpenAlex.
What is the i10-index of Luis López Lázaro?
ScholarIQi10-index
Luis López Lázaro has an i10-index of 48 in OpenAlex.
What is the ORCID of Luis López Lázaro?
ScholarIQorcid
The ORCID for Luis López Lázaro is on the source record.
What is the OpenAlex record for Luis López Lázaro?
ScholarIQopenalex
The OpenAlex for Luis López Lázaro is on the source record.
What are the most-cited papers on Luis López Lázaro?
ScholarIQmost cited works
Phase I and Pharmacokinetic Study of Ecteinascidin-743, a New Marine Compound, Administered as a 24-hour Continuous Infusion in Patients With Solid Tumors
A. Taamma, J. L. Misset, M. Riofrio, C. Guzmán, Étienne Brain, Luis López Lázaro, Hilde Rosing, José Jimeno, Esteban Cvitkovic
Erythema nodosum: Etiologic and predictive factors in a defined population
Carlos Garcı́a-Porrúa, Miguel Á. González‐Gay, Manuel Vázquez‐Caruncho, Luis López Lázaro, Mercedes Lueiro, María Lameiras Fernández, Javier Alvarez‐Ferreira, Ramón M. Pujol
Phase I and Pharmacokinetic Study of Aplidine, a New Marine Cyclodepsipeptide in Patients With Advanced Malignancies
Sandrine Faivre, Stéphanie Chièze, Catherine Delbaldo, Nora Ady-vago, Cecilia Guzmán, Luis López Lázaro, Stéphanie Lozahic, José Jimeno, Fernando Pico, Jean Pierre Armand, José A. López-Martín, Éric Raymond
Yondelis® (trabectedin, ET-743): the development of an anticancer agent of marine origin
Ch. van Kesteren, M. M. M. de Vooght, Luis López Lázaro, Ron A. A. Mathôt, Jan H.M. Schellens, José Jimeno, Jos H. Beijnen
Phase I Clinical and Pharmacokinetic Study of Kahalalide F in Patients with Advanced Androgen Refractory Prostate Cancer
Jeany M. Rademaker-Lakhai, Simon Horenblas, W. Meinhardt, Ellen Stokvis, Theo M. de Reijke, José Jimeno, Luis López Lázaro, José A. López-Martín, Jos H. Beijnen, Jan H.M. Schellens